ISSN:0112-1642    

DOI:10.2165/00007256-199112040-00001

出版商:Springer International Publishing    

年代:2012

数据来源: ADIS

ISSN:0112-1642    

DOI:10.2165/00007256-199112040-00002

出版商:Springer International Publishing    

年代:2012

数据来源: ADIS

摘要:

SummaryObesity is the presence of excess body fat and is associated with a variety of medical conditions which increase morbidity and mortality. Millions of individuals participate in weight-reduction programmes which include reduced calorie diets and may also include exercise. Very low calorie diets (VLCD) of 400 to 800 kcal/day appear attractive as they generally show an increase in weight loss from 0.2 to 0.5 kg/week found with the traditional diet to 1.5 to 2.0 kg/week. Early use of very low calorie diets with poor quality protein and loose medical supervision resulted in about 60 deaths, many of which were attributed to loss of lean body mass and in particular, cardiac muscle atrophy. Although current very low calorie diets are presumed safe, concern regarding preservation of lean body mass (LBM) remains. Investigators have used exercise to slow the depletion of lean body mass during very low calorie diets; however, the results are not conclusive. A host of different methodologies and questionable documentation and design of exercise protocols precludes a definitive statement for the benefits of exercise during very low calorie diets for the purpose of LBM retention.

ISSN:0112-1642    

DOI:10.2165/00007256-199112040-00003

出版商:Springer International Publishing    

年代:2012

数据来源: ADIS

摘要:

SummaryDrug use among athletes has become a recognised problem in sports. Athletes may use drugs for therapeutic indications, for recreational or social reasons, as ergogenic aids or to mask the presence of other drugs during drug testing.Stimulants were some of the first drugs used and studied as ergogenic aids. Amphetamines may increase time to exhaustion by masking the physiological response to fatigue. Caffeine may improve utilisation of fatty acids as a fuel source thereby sparing muscle glycogen. Cocaine and other sympathomimetic drugs have little or no effect on athletic performance.Anabolic steroids appear to have the potential to increase lean muscle mass and strength under certain conditions. Human growth hormone may also be used for an anabolic effect, but data on this effect are lacking. Erythropoietin may represent a pharmacological alternative to blood doping by increasing red blood cell mass. The use of narcotic analgesics is not necessarily ergogenic but can be harmful if used to allow participation of an athlete with a severe injury.According to the American College of Sports Medicine alcohol does not possess an ergogenic effect. However, it may be used to reduce anxiety or tremor prior to competition. Marijuana does not increase strength. Tobacco products may produce psychomotor effects or control appetite which may be beneficial to some athletes.Other drugs used by athletes include β-blocking agents, diuretics, and a variety of nutritional supplements. In addition, diuretics and probenecid may be taken to mask drug contents in the urine.Whether the ergogenic effects are real or perceived, the potential for adverse effects exists for all of these drugs. Potential health complications represent a serious risk to an otherwise healthy population. Further research on the long term health risks in athletes taking ergogenic drugs is needed.

ISSN:0112-1642    

DOI:10.2165/00007256-199112040-00004

出版商:Springer International Publishing    

年代:2012

数据来源: ADIS

摘要:

SummaryMedical records of 59 patients (9 females and 50 males), who presented to sports medicine clinics at the Australian Institute of Sport and the University of British Columbia between 1985 and 1990 and who were diagnosed as suffering osteitis pubis, were reviewed and comparison of data obtained was made with the literature. Women average 35.5 years of age (30 to 59 years) and men 30.3 years (13 to 61 years). Sports most frequently involved were running, soccer, ice hockey and tennis. Clinical presentations of osteitis pubis fell into 4 main groups. ‘Mechanical’ (sport-related) was the largest group (n = 48), followed by ‘obstetric’ (n = 5), ‘inflammatory’ (n = 4) and ‘other’ (n = 2). Period of follow-up averaged 10.3 months (1 to 20 months) in women and 17.5 months (2 to 96 months) in men. Full recovery, when documented, averaged 9.5 months in men and 7.0 months in women. Osteitis pubis recurred in 25% of these men and none of these women at follow-up. The most frequent symptoms were pubic pain and adductor pain. Men also presented with lower abdominal, hip and perineal or scrotal pain; women with hip pain. Most common signs were tenderness of the pubic symphysis and tenderness of adductor longus muscle origin. Men also revealed tenderness of one or both the superior pubic rami and evidence of decreased hip rotation (unilateral or bilateral). Evidence of pelvic malalignment and/or sacroiliac dysfunction was frequently seen in both men and women. There was poor correlation between radiographic and isotope bone scan findings and the site and duration of symptoms and signs. Femoral head ratios were estimated on 30 hips in the series and 2 were judged to be at the upper limit of normal, perhaps indicating a form of epiphysiolysis producing tilt deformity of the head of the femur.It is clear that osteitis pubis in athletes is not uncommon and that factors such as loss of rotation of hips and previous obstetric history are important in the aetiology and management of this condition. Pelvic infection, which was believed to be the primary factor of osteitis pubis in the literature up until the 1970s, plays a very small role in this condition in athletes.

ISSN:0112-1642    

DOI:10.2165/00007256-199112040-00005

出版商:Springer International Publishing    

年代:2012

数据来源: ADIS